Amino toughs out 2009; seeing better conditions in 2010

Amino Technologies plc, the Cambridge-based provider of digital entertainment software for IPTV, Internet TV and in-home multimedia distribution, said its revenue for the year to end November 2009 was down 20.7% to £25.3m, while tough trading conditions tipped into an operating loss of £5.9m compared to a profit of £1.4m in 2008.

Chairman Keith Todd said: "2009 was a challenging year for Amino resulting in a disappointing financial outcome.

"We have worked hard during the year to build a strong base for 2010, improving our product, sales and marketing and cutting cost, against a backdrop of the global market downturn and industry-wide component shortages.

"These improvements are already yielding results with more of a robust demand in H2 and into the start of this year, as evidenced by improvements in our sales booking performance.

"The IPTV market remains attractive and we are demonstrating our ability to provide best-in-class products once more.

"Furthermore, we are very excited by the prospects in the adjacent OTT market where we have invested in a new hybrid media centre offering. Encouragingly, we are able to announce today a significant contract in this market with Amino's first Western European tier one operator win."
     
The company's share price gained 11% in early trading. Amino's market capitalisation is now around £18.5m.

 



Previous articles
AVEVA 1H07 revenue, pretax profit maintains hectic pace of growth thanks to R&D spend, bouyant markets
Briefs: Alizyme misses key Phase III drug trial target; Astron Clinica partners to give free melanoma tests
Briefs: Intercytex part of group to develop US military’s Regenerative Medicine Institute
Silicon Fen Top 20 dips during March; CSR, Bango rebound
ARM reports small growth in 1H08 revenue, slip in pretax profit in tough market conditions; market warms to outlook
CAT, CSR prop up the Silicon Fen Top 20 Index in May
Phytopharm in the red but reports good progress; in product licensing talks
Xaar says trading in Q4 has not picked up, sees profits below plan
Taptu raises £6.45m in series B round; University of Cambridge’s Physics of Medicine Centre opens
BioProgress buys US-based airPharma for £4.2m; raises £6.15m in share placing
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Abingworth Management


Claire Wilkinson
General Counsel


Abingworth is a long-established venture capital firm specialising in investment in life science biomedical companies. With offices in London, Cambridge, Menlo Park and Boston, Abingworth is active on both sides of the Atlantic and has backed more than 90 developing life science/medical businesses.

[Abingworth Management's profile]


Top20 Index




Currently: 161